Steven J. Bensinger

Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (6)

Infections after psychological stress are a major health care problem. Single-cell transcriptomics and lipidomic profiling in a mouse model of stress show that dermal fibroblasts undergoing adipogenesis have defective responses to Staphylococcus aureus skin infection. Adrenalectomy or adrenergic inhibition restores the fibroblast adipogenic response to S. aureus and enables mice to effectively resist infection during stress. Increased susceptibility to S. aureus from stress is attributed to suppression of the antimicrobial peptide cathelicidin ( Camp ) because adrenaline directly inhibits Camp production by fibroblasts, and mice lacking Camp in fibroblasts do not increase infection after stress. Transforming growth factor β (TGFβ) is induced by stress and adrenergic signaling, and inhibition of TGFβ or deletion of the TGFβ receptor on fibroblasts increases Camp expression and restores protection against infection. Together, these data show that stress initiates a brain-skin axis mediated by TGFβ that impairs the immune defense function of dermal fibroblasts to produce the Camp antimicrobial peptide.

Year:

2025

The intrinsic pathways that control membrane organization in immune cells and their impact on cellular functions are poorly defined. We found that the nonvesicular cholesterol transporter Aster-A linked plasma membrane (PM) cholesterol availability in CD4 T cells to systemic metabolism. Aster-A was recruited to the PM during T cell receptor (TCR) activation, where it facilitated the removal of accessible cholesterol. Loss of Aster-A increased cholesterol accumulation in the PM, which enhanced TCR nanoclustering and signaling. Aster-A associated with stromal interaction molecule 1 (STIM1) and negatively regulated calcium (Ca 2+ ) flux. Aster-A deficiency promoted CD4 T cells to acquire a T helper 17 (T H 17) phenotype and stimulated interleukin-22 production, which reduced intestinal fat absorption and conferred resistance to diet-induced obesity. These findings delineate how immune cell membrane homeostasis links to systemic physiology.

Year:

2025

Small molecules that induce non-apoptotic cell death are of fundamental mechanistic interest and may be useful to treat certain cancers. Here, we report that tegavivint, a drug candidate undergoing human clinical trials, can activate a unique mechanism of non-apoptotic cell death in sarcomas and other cancer cells. This lethal mechanism is distinct from ferroptosis, necroptosis and pyroptosis and requires the lipid metabolic enzyme trans -2,3-enoyl-CoA reductase (TECR). TECR is canonically involved in the synthesis of very long chain fatty acids but appears to promote non-apoptotic cell death in response to CIL56 and tegavivint via the synthesis of the saturated long-chain fatty acid palmitate. These findings outline a lipid-dependent non-apoptotic cell death mechanism that can be induced by a drug candidate currently being tested in humans.

Year:

2025

Pro-inflammatory macrophage activation is a hallmark example of how mitochondria serve as signaling organelles. Oxidative phosphorylation sharply decreases upon classical macrophage activation, as mitochondria are thought to shift from ATP production towards accumulating signals that amplify effector function. However, evidence is conflicting regarding whether this collapse in respiration is essential or dispensable. Here we systematically examine this question and show that reduced oxidative phosphorylation is not required for pro-inflammatory macrophage activation. Different pro-inflammatory stimuli elicit varying effects on bioenergetic parameters, and pharmacologic and genetic models of electron transport chain inhibition show no causative link between respiration and macrophage activation. Furthermore, the signaling metabolites succinate and itaconate can accumulate independently of characteristic breaks in the TCA cycle in mouse and human macrophages, and peritoneal macrophages can be activated in vivo without inhibition of oxidative phosphorylation. The results indicate there is plasticity in the metabolic phenotypes that can support pro-inflammatory macrophage activation.

Year:

2025

The intrinsic pathways that control membrane organization in immune cells and the impact of such pathways on cellular function are not well defined. Here we report that the non-vesicular cholesterol transporter Aster-A links plasma membrane (PM) cholesterol availability in T cells to immune signaling and systemic metabolism. Aster-A is recruited to the PM during T-cell receptor (TCR) activation, where it facilitates the removal of newly generated “accessible” membrane cholesterol. Loss of Aster-A leads to excess PM cholesterol accumulation, resulting in enhanced TCR nano-clustering and signaling, and Th17 cytokine production. Finally, we show that the mucosal Th17 response is restrained by PM cholesterol remodeling. Ablation of Aster-A in T cells leads to enhanced IL-22 production, reduced intestinal fatty acid absorption, and resistance to diet-induced obesity. These findings delineate a multi-tiered regulatory scheme linking immune cell lipid flux to nutrient absorption and systemic physiology.

Year:

2024

Summary The mevalonate pathway is an essential metabolic pathway in T cells regulating development, proliferation, survival, differentiation, and effector functions. The mevalonate pathway is a complex, branched pathway composed of many enzymes that ultimately generate cholesterol and nonsterol isoprenoids. T cells must tightly control metabolic flux through the branches of the mevalonate pathway to ensure sufficient isoprenoids and cholesterol are available to meet cellular demands. Unbalanced metabolite flux through the sterol or the nonsterol isoprenoid branch is metabolically inefficient and can have deleterious consequences for T cell fate and function. Accordingly, there is tight regulatory control over metabolic flux through the branches of this essential lipid synthetic pathway. In this review we provide an overview of how the branches of the mevalonate pathway are regulated in T cells and discuss our current understanding of the relationship between mevalonate metabolism, cholesterol homeostasis and T cell function.

Year:

2023

Collaborators (23)

Cristiane Benincá

University of California

UNITED STATES
View details

Charles Boone

Professor

University of Toronto

CANADA
View details

Hung (Marcus) Chan

Research Assistant Professor

Hong Kong Baptist University

HONG KONG
View details

Alessandra Ferrari

Assistant Professor

University of California, Berkeley

UNITED STATES
View details

Orian S Shirihai

University of California

UNITED STATES
View details

John Paul Kennelly

University of California, Los Angeles

UNITED STATES
View details

Xu Xiao

Assistant Professor

University of Kentucky

UNITED STATES
View details

Everett J. Moding

Stanford University

UNITED STATES
View details

Stephen Young

Distinguished Professor

Ronald Reagan UCLA Medical Center

UNITED STATES
View details

Julia Mack

Assistant Adjunct Professor

University of California, Los Angeles

UNITED STATES
View details

Jason Moffat

Senior Scientist and Program Head

Hospital for Sick Children

CANADA
View details

Scott Dixon

Associate Professor

Stanford University

UNITED STATES
View details

Chad L Myers

Professor

University of Minnesota

UNITED STATES
View details

Whitaker Cohn

Associate Director, Multi-Omics Mass Spectrometry Core / Adjunct Assistant Professor of Clinical Pharmacy

University of Southern California

UNITED STATES
View details

Yajing Gao

Assistant Professor

University of Utah

UNITED STATES
View details

Brianna Johnson

Rockefeller University

UNITED STATES
View details

Tomofumi Numata

Associate professor (Special Appointment)

Hiroshima University

JAPAN
View details

Ajit S Divakaruni

-

UNITED STATES
View details

Lauren Uchiyama

University of California, Los Angeles

UNITED STATES
View details

Isaac Chiu

Professor

Harvard Medical School

UNITED STATES
View details

Alexander Nguyen

David Geffen School of Medicine at UCLA

UNITED STATES
View details

Yousang Gwack

Professor

University of California, Los Angeles

UNITED STATES
View details

Richard Gallo

University of California, San Diego

UNITED STATES
View details